National Institute of Mental Health; Notice of Meeting, 69091-69092 [2010-28299]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices
Contact Person: Philippe Marmillot, PhD,
Scientific Review Officer, National Institutes
of Health, National Institute on Alcohol
Abuse and Alcoholism, 5635 Fishers Lane,
Room 2019, Bethesda, MD 20892, 301–443–
2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical Treatment and
Health Services Research Review
Subcommittee.
Date: March 15–16, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Katrina Foster, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2019, Rockville, MD 20852, 301–443–4032,
katrinaf@mail.nih.gov.
18:25 Nov 09, 2010
Jkt 223001
[FR Doc. 2010–28374 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Director, Office of
Biotechnology Activities; Notice of
Meeting
BILLING CODE 4140–01–P
VerDate Mar<15>2010
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–28376 Filed 11–9–10; 8:45 am]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
There will be a workshop entitled
‘‘Retroviral and Lentiviral Vectors for
Long-Term Gene Correction: Clinical
Challenges in Vector and Trial Design.’’
The meeting will be open to the public;
attendance is limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: December 9, 2010.
Time: 8 a.m. to 5:30 p.m.
Date: December 10, 2010.
Time: 8 a.m. to 1 p.m.
Agenda: The Office of Biotechnology
Activities (OBA), NIH Recombinant DNA
Advisory Committee and the European
Network for the Advancement of Clinical
Gene Transfer (CliniGene) will host a
workshop on Retroviral and Lentiviral
Vectors for Long-Term Gene Correction:
Clinical Challenges in Vector and Trial
Design at the Bethesda Marriott on December
9 and 10, 2010. The meeting will cover the
following topics: Developments in retrovirus
and lentivirus integration and insertional
mutagenesis research, including nonenhancer mediated mechanisms of
insertional mutagenesis; modifications to
retroviral and lentiviral vectors to enhance
their safety; research on in vitro and animal
models to evaluate the safety of human gene
transfer; and ethical issues in the design of
new clinical trials. The agenda is posted to
OBA’s Web site: https://oba.od.nih.gov/
rdna_rac/rac_meetings.html. Please check
the meeting agenda for more information.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, Maryland 20814.
Contact Person: Chezelle George, Program
Assistant, Office of Science Policy, Office of
Biotechnology Activities, National Institutes
of Health, 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, 301–496–9838, 301–
496–9839, georgec@mail.nih.gov.
Any interested person may file written
comments with the panel by forwarding the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
69091
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Background information may be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov
Dated: November 1, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology
Activities, National Institutes of Health.
[FR Doc. 2010–28373 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Interagency Autism Coordinating
Committee (IACC) Subcommittee on
Safety.
The Interagency Autism Coordinating
Committee (IACC) Subcommittee on
Safety will be meeting on Monday,
November 29, 2010. The subcommittee
plans to discuss issues related to autism
and safety. This meeting will be open to
the public and will be accessible
through a conference call.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of Meeting: Subcommittee on Safety.
Date: November 29, 2010.
Time: 9 a.m. to 12 p.m. Eastern Time.
Agenda: To discuss issues related to
autism and safety.
Place: The Neuroscience Center, 6001
Executive Boulevard, Conference Room B1/
B2, Rockville, MD 20852.
Conference Call Access: Dial: 800–369–
1754. Access code: 5105457.
Cost: The meeting is free and open to the
public.
Registration: https://
www.acclaroresearch.com/oarc/11–29–10/.
Pre-registration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis.
Access: Metro accessible—White Flint
Metro (Red Line).
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, NSC, Room 8185a,
Rockville, MD 20852. Phone: 301–443–6040.
E-mail: IACCPublicInquiries@mail.nih.gov.
Please Note:
The meeting will be open to the public and
accessible through a conference call.
Members of the public who participate using
the conference call phone number will be
E:\FR\FM\10NON1.SGM
10NON1
69092
Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices
able to listen to the meeting but will not be
heard. If you experience any technical
problems with the conference call, please email:
IACCTechSupport@acclaroresearch.com.
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least 7 days prior to the meeting.
As a part of security procedures, attendees
should be prepared to present a photo ID at
the meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited to the
room capacity and seats will be on a first
come, first served basis, with expedited
check-in for those who are pre-registered.
Please note: Online pre-registration will close
by 5 p.m. the day before the meeting. After
that time, registration will have to be done
onsite the day of the meeting.
Meeting schedule subject to change.
Information about the IACC and a
registration link for this meeting are available
on the Web site: http//:www.iacc.hhs.gov.
Dated: November 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel MBRS SCORE Meeting.
Date: December 2–3, 2010.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN12, Bethesda, MD 20892. (Virtual
Meeting)
Jkt 223001
[FR Doc. 2010–28298 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of General Medical
Sciences; Notice of Closed Meeting
BILLING CODE 4140–01–P
18:25 Nov 09, 2010
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–28299 Filed 11–9–10; 8:45 am]
VerDate Mar<15>2010
Contact Person: Lisa Dunbar, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN12, Bethesda,
MD 20892. 301–594–2849.
dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel MBRS Behavioral Science Panel.
Date: December 2, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN18, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: Rebecca H. Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892. 301–594–2771.
johnsonrh@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–28297 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive And Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, DDK–B Conflicts.
Date: December 2, 2010.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: Ann A. Jerkins, PhD,
Scientific Review Officer, Review Branch,
Dea, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452. 301–594–2242.
Jerkinsa@Niddk.Nih.Gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, CKD And CVD
Ancillary Studies.
Date: December 17, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
E:\FR\FM\10NON1.SGM
10NON1
]]>Agencies
[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Pages 69091-69092]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28299]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Interagency Autism Coordinating Committee (IACC) Subcommittee on
Safety.
The Interagency Autism Coordinating Committee (IACC) Subcommittee
on Safety will be meeting on Monday, November 29, 2010. The
subcommittee plans to discuss issues related to autism and safety. This
meeting will be open to the public and will be accessible through a
conference call.
Name of Committee: Interagency Autism Coordinating Committee
(IACC).
Type of Meeting: Subcommittee on Safety.
Date: November 29, 2010.
Time: 9 a.m. to 12 p.m. Eastern Time.
Agenda: To discuss issues related to autism and safety.
Place: The Neuroscience Center, 6001 Executive Boulevard,
Conference Room B1/B2, Rockville, MD 20852.
Conference Call Access: Dial: 800-369-1754. Access code:
5105457.
Cost: The meeting is free and open to the public.
Registration: https://www.acclaroresearch.com/oarc/11-29-10/.
Pre-registration is recommended to expedite check-in. Seating in the
meeting room is limited to room capacity and on a first come, first
served basis.
Access: Metro accessible--White Flint Metro (Red Line).
Contact Person: Ms. Lina Perez, Office of Autism Research
Coordination, National Institute of Mental Health, NIH, 6001
Executive Boulevard, NSC, Room 8185a, Rockville, MD 20852. Phone:
301-443-6040. E-mail: IACCPublicInquiries@mail.nih.gov.
Please Note:
The meeting will be open to the public and accessible through a
conference call. Members of the public who participate using the
conference call phone number will be
[[Page 69092]]
able to listen to the meeting but will not be heard. If you
experience any technical problems with the conference call, please
e-mail: IACCTechSupport@acclaroresearch.com.
Individuals who participate in person or by using these
electronic services and who need special assistance, such as
captioning of the conference call or other reasonable
accommodations, should submit a request to the Contact Person listed
on this notice at least 7 days prior to the meeting.
As a part of security procedures, attendees should be prepared
to present a photo ID at the meeting registration desk during the
check-in process. Pre-registration is recommended. Seating will be
limited to the room capacity and seats will be on a first come,
first served basis, with expedited check-in for those who are pre-
registered. Please note: Online pre-registration will close by 5
p.m. the day before the meeting. After that time, registration will
have to be done onsite the day of the meeting.
Meeting schedule subject to change.
Information about the IACC and a registration link for this
meeting are available on the Web site: http//:www.iacc.hhs.gov.
Dated: November 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-28299 Filed 11-9-10; 8:45 am]
BILLING CODE 4140-01-P
